BMJ. 2019 Jul 25;366:l4292. doi: 10.1136/bmj.l4292.
To investigate whether the genetic burden of type 2 diabetes modifies the association between the quality of dietary fat and the incidence of type 2 diabetes.
Individual participant data meta-analysis.
Eligible prospective cohort studies were systematically sourced from studies published between January 1970 and February 2017 through electronic searches in major medical databases (Medline, Embase, and Scopus) and discussion with investigators.
Data from cohort studies or multicohort consortia with available genome-wide genetic data and information about the quality of dietary fat and the incidence of type 2 diabetes in participants of European descent was sought. Prospective cohorts that had accrued five or more years of follow-up were included. The type 2 diabetes genetic risk profile was characterized by a 68-variant polygenic risk score weighted by published effect sizes. Diet was recorded by using validated cohort-specific dietary assessment tools. Outcome measures were summary adjusted hazard ratios of incident type 2 diabetes for polygenic risk score, isocaloric replacement of carbohydrate (refined starch and sugars) with types of fat, and the interaction of types of fat with polygenic risk score.
Of 102 305 participants from 15 prospective cohort studies, 20 015 type 2 diabetes cases were documented after a median follow-up of 12 years (interquartile range 9.4-14.2). The hazard ratio of type 2 diabetes per increment of 10 risk alleles in the polygenic risk score was 1.64 (95% confidence interval 1.54 to 1.75, I=7.1%, τ=0.003). The increase of polyunsaturated fat and total omega 6 polyunsaturated fat intake in place of carbohydrate was associated with a lower risk of type 2 diabetes, with hazard ratios of 0.90 (0.82 to 0.98, I=18.0%, τ=0.006; per 5% of energy) and 0.99 (0.97 to 1.00, I=58.8%, τ=0.001; per increment of 1 g/d), respectively. Increasing monounsaturated fat in place of carbohydrate was associated with a higher risk of type 2 diabetes (hazard ratio 1.10, 95% confidence interval 1.01 to 1.19, I=25.9%, τ=0.006; per 5% of energy). Evidence of small study effects was detected for the overall association of polyunsaturated fat with the risk of type 2 diabetes, but not for the omega 6 polyunsaturated fat and monounsaturated fat associations. Significant interactions between dietary fat and polygenic risk score on the risk of type 2 diabetes (P>0.05 for interaction) were not observed.
These data indicate that genetic burden and the quality of dietary fat are each associated with the incidence of type 2 diabetes. The findings do not support tailoring recommendations on the quality of dietary fat to individual type 2 diabetes genetic risk profiles for the primary prevention of type 2 diabetes, and suggest that dietary fat is associated with the risk of type 2 diabetes across the spectrum of type 2 diabetes genetic risk.
研究 2 型糖尿病的遗传负担是否会改变膳食脂肪质量与 2 型糖尿病发病之间的关联。
个体参与者数据的荟萃分析。
通过对主要医学数据库(Medline、Embase 和 Scopus)的电子检索,以及与研究人员的讨论,系统性地从 1970 年 1 月至 2017 年 2 月发表的前瞻性队列研究中获取了符合条件的研究。纳入了有可用全基因组遗传数据以及参与者中膳食脂肪质量和 2 型糖尿病发病情况的队列研究或多队列联盟。纳入了随访时间至少 5 年的前瞻性队列。2 型糖尿病遗传风险概况由经过发表的效应量加权的 68 个变异多基因风险评分来描述。采用经过验证的队列特异性膳食评估工具来记录饮食。结局指标为多基因风险评分、用脂肪替代碳水化合物(精制淀粉和糖)的等热量替代以及脂肪类型与多基因风险评分之间的交互作用对 2 型糖尿病发病的综合校正危害比。
在来自 15 项前瞻性队列研究的 102305 名参与者中,中位随访 12 年后(四分位间距 9.4-14.2)记录到 20015 例 2 型糖尿病病例。多基因风险评分每增加 10 个风险等位基因,2 型糖尿病的发病风险比为 1.64(95%置信区间 1.54 至 1.75,I=7.1%,τ=0.003)。用多不饱和脂肪和总 omega 6 多不饱和脂肪替代碳水化合物的摄入与较低的 2 型糖尿病发病风险相关,危害比分别为 0.90(0.82 至 0.98,I=18.0%,τ=0.006;每 5%能量)和 0.99(0.97 至 1.00,I=58.8%,τ=0.001;每增加 1 g/d)。用单不饱和脂肪替代碳水化合物与 2 型糖尿病发病风险升高相关(危害比 1.10,95%置信区间 1.01 至 1.19,I=25.9%,τ=0.006;每 5%能量)。多不饱和脂肪与 2 型糖尿病发病风险之间的整体关联存在小研究效应的证据,但 omega 6 多不饱和脂肪和单不饱和脂肪之间的关联没有这种证据。在 2 型糖尿病发病风险方面,未观察到膳食脂肪与多基因风险评分之间存在显著的交互作用(交互作用 P>0.05)。
这些数据表明,遗传负担和膳食脂肪质量均与 2 型糖尿病的发病有关。这些发现并不支持根据 2 型糖尿病的个体遗传风险概况来专门调整膳食脂肪质量,以预防 2 型糖尿病,而且提示膳食脂肪与 2 型糖尿病遗传风险谱中的 2 型糖尿病发病风险相关。